Authors:
Bergeron, Y
Gauthier, S
Kafka, V
Lefort, P
Lesieur, D
Citation: Y. Bergeron et al., Natural fire frequency for the eastern Canadian boreal forest: consequences for sustainable forestry, CAN J FORES, 31(3), 2001, pp. 384-391
Authors:
Chavatte, P
Yous, S
Lesieur, D
Henichart, JP
Citation: P. Chavatte et al., Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH, J PHARM PHA, 53(7), 2001, pp. 949-953
Authors:
Chavatte, P
Yous, S
Marot, C
Baurin, N
Lesieur, D
Citation: P. Chavatte et al., Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: A comparative molecular field analysis, J MED CHEM, 44(20), 2001, pp. 3223-3230
Authors:
Delhomel, JF
Yous, S
Depreux, P
Lesieur, D
Citation: Jf. Delhomel et al., Synthesis of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives as potential beta-3-adrenergic receptor ligands (part 2), J HETERO CH, 38(3), 2001, pp. 633-639
Authors:
Merle, A
Delagrange, P
Renard, P
Lesieur, D
Cuber, JC
Roche, M
Pellissier, S
Citation: A. Merle et al., Effect of melatonin on motility pattern of small intestine in rats and itsinhibition by melatonin receptor antagonist S 22153, J PINEAL R, 29(2), 2000, pp. 116-124
Authors:
Varlet, D
Fourmaintraux, E
Depreux, P
Lesieur, D
Citation: D. Varlet et al., Synthesis of 4-[4 '-(N-N-dimethylsulfamoyl)piperazin-1-yl]-pyridine derivatives as sorbitol dehydrogenase potential inhibitors, HETEROCYCLE, 53(4), 2000, pp. 797-804
Authors:
Ferry, G
Loynel, A
Kucharczyk, N
Bertin, S
Rodriguez, M
Delagrange, P
Galizzi, JP
Jacoby, E
Volland, JP
Lesieur, D
Renard, P
Canet, E
Fauchere, JL
Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase (vol 275, pg 8794, 2000), J BIOL CHEM, 275(50), 2000, pp. 39799-39799
Authors:
Ferry, G
Loynel, AM
Kucharczyk, N
Bertin, S
Rodriguez, M
Delagrange, P
Galizzi, JP
Jacoby, E
Volland, JP
Lesieur, D
Renard, P
Canet, E
Fauchere, JL
Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase, J BIOL CHEM, 275(12), 2000, pp. 8794-8805
Authors:
Conway, S
Canning, SJ
Howell, HE
Mowat, ES
Barrett, P
Drew, JE
Delagrange, P
Lesieur, D
Morgan, PJ
Citation: S. Conway et al., Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay, EUR J PHARM, 390(1-2), 2000, pp. 15-24
Authors:
Gozzo, A
Lesieur, D
Duriez, P
Fruchart, JC
Teissier, E
Citation: A. Gozzo et al., Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model, FREE RAD B, 26(11-12), 1999, pp. 1538-1543
Authors:
Liacha, M
Yous, S
Depreux, P
Poupaert, JH
Lesieur, D
Citation: M. Liacha et al., Synthesis of N-(4,6-dimethylpyridin-2-yl)-benzoxazolinonyl methylcarboxamides with potential antiinflammatory activity, HETEROCYCLE, 51(8), 1999, pp. 1929-1943
Authors:
Kopp, C
Vogel, E
Rettori, MC
Delagrange, P
Renard, P
Lesieur, D
Misslin, R
Citation: C. Kopp et al., Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on theneophobia-reducing properties of melatonin in BALB/c mice, PHARM BIO B, 64(1), 1999, pp. 131-136
Authors:
Weibel, L
Rettori, MC
Lesieur, D
Delagrange, P
Renard, P
Van Reeth, O
Citation: L. Weibel et al., A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice, BRAIN RES, 829(1-2), 1999, pp. 160-166